Azilect 1 mg Oral Tablet
RxNorm 637185
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 637185 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Azilect 1 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Azilect 1 mg (as rasagiline mesylate) Oral Tablet
(Atom ID: 6343672)
PSNPrescribable
Prescribable Name (PSN):
Azilect 1 mg Oral Tablet
(Atom ID: 6359244)
SYPrescribable
Synonym (SY):
Azilect 1 mg Oral Tablet
(Atom ID: 2534240)
SBDPrescribable
Semantic Branded Drug (SBD):
Rasagiline 1 mg Oral Tablet [Azilect]
(Atom ID: 2534239)
Patient Education
Rasagiline
Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.